Note 14 - Segment and Geographic Information

9 Months Ended

Sep. 30, 2013

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

14. Segment and Geographic Information

The Company has one reportable operating segment, the results of which are disclosed in the accompanying unaudited condensed consolidated financial statements.

Product revenue by product group is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
Orthobiologics	$	12,830,566	$	9,242,783	$	40,620,339	$	30,262,991
Dermal		267,766		376,251		1,066,409		1,033,302
Surgical		1,136,248		1,426,273		3,955,134		3,874,405
Ophthalmic		1,425,609		1,891,433		2,818,407		8,515,160
Veterinary		1,363,157		1,118,700		3,124,953		2,865,187
Product revenue	$	17,023,346	$	14,055,440	$	51,585,242	$	46,551,045

Total revenue by geographic location in total and as a percentage of total revenue, for the three and nine months ended September 30, 2013 and 2012 are as follows (prior period numbers have been reclassified to conform to current period presentation):

	Three Months Ended September 30,
	2013					2012
	Revenue		Percentage of Revenue			Revenue		Percentage of Revenue
Geographic Location:
United States	$	14,485,821		82	%	$	12,628,612		86	%
Europe		1,656,656		9	%		1,064,165		7	%
Other		1,611,961		9	%		1,073,834		7	%
Total revenue	$	17,754,438		100	%	$	14,766,611		100	%

	Nine Months Ended September 30,
	2013					2012
	Revenue		Percentage of Revenue			Revenue		Percentage of Revenue
Geographic Location:
United States	$	42,251,336		78	%	$	40,463,657		83	%
Europe		5,226,619		10	%		3,993,708		8	%
Other		6,351,871		12	%		4,294,675		9	%
Total revenue	$	53,829,826		100	%	$	48,752,040		100	%